Why Use Estrogen Patches for Turner Syndrome?
At a Glance
Doctors recommend transdermal estrogen patches over oral pills for Turner syndrome because patches deliver hormones directly into the bloodstream. This bypasses the liver, preventing interference with growth hormone treatments, reducing blood clot risks, and better mimicking natural puberty.
In this answer
4 sections
When starting hormone replacement therapy (HRT) for Turner syndrome, doctors typically recommend transdermal estrogen—delivered through patches or gels—rather than the familiar oral birth control pill. The primary reason is that patches deliver estrogen directly into the bloodstream through the skin, closely mimicking how natural ovaries release hormones [1][2]. By avoiding the digestive system, patches provide a more natural balance of hormones, better support for bone and cardiovascular health, and fewer metabolic side effects than oral synthetic pills [3][4]. (Note: While estrogen starts the puberty process, your doctor will eventually add progesterone to complete the long-term HRT plan and protect the uterus).
Bypassing the Liver: The First-Pass Effect
When someone takes a traditional estrogen pill, the medication must first pass through the stomach and be processed by the liver before entering the rest of the body [3]. This processing is known as first-pass metabolism.
Processing oral estrogen in the liver changes how the body handles the hormone in several critical ways:
- Impact on growth: If your daughter is also taking growth hormone therapy, oral estrogen can interfere with the liver’s production of Insulin-like Growth Factor 1 (IGF-1), which is crucial for growth [1]. Transdermal estrogen avoids this liver interaction, allowing growth hormone treatments to work more effectively.
- Altered hormone balance: The liver converts a large amount of the active estrogen (estradiol) into a weaker, less biologically potent form called estrone [5]. Transdermal patches bypass the liver, maintaining a natural, healthy ratio of estradiol to estrone [5][6].
- Mimicking natural puberty: Clinical guidelines prefer low-dose patches because they allow doctors to create a slow, gradual increase in hormone levels over two to three years, accurately mimicking natural pubertal development [2][1].
Protecting Heart Health and Blood Pressure
Girls and women with Turner syndrome often have unique cardiovascular risks, making heart-healthy choices a priority throughout their lifespan.
Research shows that transdermal estrogen offers a superior cardiovascular safety profile compared to oral estrogen [7][8]. Standard oral contraceptives (birth control pills) have been associated with higher blood pressure and less favorable cholesterol profiles in patients with Turner syndrome [9]. In contrast, transdermal patches do not place the same strain on the liver’s production of clotting factors, resulting in a significantly lower risk of venous thromboembolism (dangerous blood clots) [3][10].
Building Stronger Bones
Estrogen is essential for developing strong bones, which is a key focus in Turner syndrome care. While both pills and patches help improve bone density, studies suggest that natural transdermal estradiol is more effective at building optimal bone mineral density in young women than the synthetic ethinylestradiol commonly found in oral birth control pills [4][11].
Practical Considerations for Patches
While patches are the standard of care for their physiological benefits, they do require some routine adjustments for a child:
- Active lifestyles: Transdermal patches are waterproof. Your daughter can safely swim, shower, sweat in gym class, and play sports while wearing them.
- Dosing and cutting: Because pediatric doses to start puberty are much lower than adult menopause doses, doctors often instruct parents to cut adult patches to get a precise fraction. Note: Only “matrix” style patches can be cut safely; “reservoir” style patches will leak the active hormone if cut. Always confirm the type of patch with your pharmacist.
- Skin sensitivity: Patches are typically applied to the lower abdomen or buttocks and changed once or twice a week. If the adhesive causes skin irritation, doctors can suggest different brands or a daily transdermal gel.
By using transdermal estrogen, your daughter’s care team is providing a treatment that works in harmony with her body’s natural systems, optimizing her long-term health while safely supporting her development.
Common questions in this guide
Why are estrogen patches better than pills for Turner syndrome?
Can my child swim and play sports with an estrogen patch?
Is it safe to cut an estrogen patch for a child's lower dose?
How does oral estrogen affect growth hormone therapy?
What should I do if the estrogen patch causes skin irritation?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since we are starting with a low pediatric dose to mimic natural puberty, will we need to cut adult patches, and if so, which types are safe to cut?
- 2.How will starting the estrogen patch affect my daughter's current growth hormone therapy and IGF-1 levels?
- 3.Are there specific brands of patches that stay on better for active children who swim or play sports?
- 4.At what point in her development will we need to introduce progesterone to her hormone replacement plan?
- 5.If my daughter experiences skin irritation from the patch adhesive, what alternative transdermal options or barrier methods do you recommend?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Pubertal induction in Turner syndrome without gonadal function: A possibility of earlier, lower-dose estrogen therapy.
Hasegawa Y, Hasegawa T, Satoh M, et al.
Frontiers in endocrinology 2023; (14()):1051695 doi:10.3389/fendo.2023.1051695.
PMID: 37056677 - 2
Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations.
Klein KO, Rosenfield RL, Santen RJ, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(5)):1790-1803 doi:10.1210/jc.2017-02183.
PMID: 29438552 - 3
Isolated Cortical Vein Thrombosis in a Young Woman on Transdermal Ethinyl Estradiol: Case Report and Literature Review.
Ramadan S, Okda M, Kansal D, Thompson B
AACE endocrinology and diabetes 2026; (13(1)):31-36 doi:10.1016/j.aed.2025.09.009.
PMID: 41641312 - 4
Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: a randomised clinical trial.
Ackerman KE, Singhal V, Baskaran C, et al.
British journal of sports medicine 2019; (53(4)):229-236 doi:10.1136/bjsports-2018-099723.
PMID: 30301734 - 5
Estrone - a partial estradiol antagonist in the normal breast.
Lundström E, Conner P, Naessén S, et al.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2015; (31(9)):747-9 doi:10.3109/09513590.2015.1062866.
PMID: 26190536 - 6
Why Chitosan? From properties to perspective of mucosal drug delivery.
Kumar A, Vimal A, Kumar A
International journal of biological macromolecules 2016; (91()):615-22.
PMID: 27196368 - 7
Cardiovascular health and the menopause, metabolic health.
Anagnostis P, Stevenson JC
Best practice & research. Clinical endocrinology & metabolism 2024; (38(1)):101781 doi:10.1016/j.beem.2023.101781.
PMID: 37183085 - 8
Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
Scarabin PY
Climacteric : the journal of the International Menopause Society 2018; (21(4)):341-345 doi:10.1080/13697137.2018.1446931.
PMID: 29570359 - 9
Effects of Estrogen Therapies on Outcomes in Turner Syndrome: Assessment of Induction of Puberty and Adult Estrogen Use.
Cameron-Pimblett A, Davies MC, Burt E, et al.
The Journal of clinical endocrinology and metabolism 2019; (104(7)):2820-2826 doi:10.1210/jc.2018-02137.
PMID: 30726925 - 10
The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
Anagnostis P, Galanis P, Chatzistergiou V, et al.
Maturitas 2017; (99()):27-36 doi:10.1016/j.maturitas.2017.02.009.
PMID: 28364865 - 11
Estrogen for the Treatment of Low Bone Mineral Density in Anorexia Nervosa.
Thavaraputta S, Fazeli PK
Journal of psychiatry and brain science 2022; (7(3)) doi:10.20900/jpbs.20220004.
PMID: 35874115
This page provides educational information about hormone replacement therapy for Turner syndrome. Always consult with your pediatric endocrinologist before starting or adjusting hormone treatments.
Get notified when new evidence is published on Turner syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.